tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

KYMR Stock Latest News

Kymera Therapeutics appoints Goodman as Chief Business Officer
The FlyKymera Therapeutics appoints Goodman as Chief Business Officer
9d ago
KYMR
Cautious Hold Rating on Kymera Therapeutics Amid Promising KT-621 Prospects and Strategic Developments
PremiumRatings
Cautious Hold Rating on Kymera Therapeutics Amid Promising KT-621 Prospects and Strategic Developments
15d ago
KYMR
Kymera Therapeutics initiated with a Buy at Citi
PremiumThe Fly
Kymera Therapeutics initiated with a Buy at Citi
1M ago
KYMR
Kymera Therapeutics: Leading the Way with Innovative STAT6 Degrader KT-621
PremiumRatings
Kymera Therapeutics: Leading the Way with Innovative STAT6 Degrader KT-621
1M ago
KYMR
Kymera Therapeutics: Promising Prospects in STAT6 Targeting with KT-621
PremiumRatings
Kymera Therapeutics: Promising Prospects in STAT6 Targeting with KT-621
1M ago
KYMR
Kymera Therapeutics Grants Performance Stock Units to Executives
PremiumCompany AnnouncementsKymera Therapeutics Grants Performance Stock Units to Executives
2M ago
8K
KYMR
Kymera Therapeutics: Promising Pipeline and Strategic Developments Drive Buy Rating
Premium
Ratings
Kymera Therapeutics: Promising Pipeline and Strategic Developments Drive Buy Rating
2M ago
KYMR
Kymera Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Kymera Therapeutics’ Earnings Call Highlights Progress and Challenges
2M ago
KYMR
Kymera Therapeutics: Balancing Promising Pipeline Advancements with Clinical Success Uncertainties
PremiumRatings
Kymera Therapeutics: Balancing Promising Pipeline Advancements with Clinical Success Uncertainties
2M ago
KYMR
Kymera Therapeutics: Buy Rating Affirmed Amid Promising STAT6 Program Developments and Adjusted Price Target
PremiumRatings
Kymera Therapeutics: Buy Rating Affirmed Amid Promising STAT6 Program Developments and Adjusted Price Target
2M ago
KYMR
Kymera Therapeutics price target lowered to $54 from $60 at H.C. Wainwright
PremiumThe Fly
Kymera Therapeutics price target lowered to $54 from $60 at H.C. Wainwright
2M ago
KYMR
Kymera Therapeutics: Promising Developments and Strategic Positioning Make It a Compelling Buy
PremiumRatings
Kymera Therapeutics: Promising Developments and Strategic Positioning Make It a Compelling Buy
2M ago
KYMR
Kymera Therapeutics Reports 2024 Financial Results and Pipeline Progress
PremiumCompany AnnouncementsKymera Therapeutics Reports 2024 Financial Results and Pipeline Progress
2M ago
KYMR
Kymera Therapeutics reports Q4 EPS (88c), consensus (79c)
Premium
The Fly
Kymera Therapeutics reports Q4 EPS (88c), consensus (79c)
2M ago
KYMR
Is KYMR a Buy, Before Earnings?
Premium
Pre-Earnings
Is KYMR a Buy, Before Earnings?
2M ago
KYMR
Kymera Therapeutics Unveils 2025 Strategy and Trials
PremiumCompany Announcements
Kymera Therapeutics Unveils 2025 Strategy and Trials
3M ago
8K
KYMR
Kymera Therapeutics announces corporate goals for 2025
PremiumThe Fly
Kymera Therapeutics announces corporate goals for 2025
3M ago
KYMR
Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
PremiumThe Fly
Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
4M ago
JNJ
KYMR
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
PremiumThe Fly
Capricor, Gilead, Kymera, Praxis among Oppenheimer’s top biotech picks for 2025
4M ago
CAPR
GILD
Kymera Therapeutics initiated with a Buy at BTIG
PremiumThe FlyKymera Therapeutics initiated with a Buy at BTIG
4M ago
KYMR
Kymera Therapeutics initiated with a Market Perform at BMO Capital
Premium
The Fly
Kymera Therapeutics initiated with a Market Perform at BMO Capital
4M ago
KYMR
Kymera Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
Premium
The Fly
Kymera Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo
5M ago
KYMR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >